13 March, 2025: The University of Liverpool has introduced the Eye Cancer Artificial Intelligence Digital Bioresource (EYE-CAN-AID)—a groundbreaking initiative aimed at improving early detection and treatment of rare eye cancers. The launch featured cutting-edge technology from Roche Diagnostics, including the VENTANA DP 600 digital pathology slide scanner. This high-resolution
10 March 2025: The UK Government has accepted the majority of recommendations from the Regulatory Horizons Council (RHC) regarding the regulation of artificial intelligence (AI) in medical devices, aiming to balance patient safety with innovation. Government Endorsement of AI in MedTech Regulations The Department for Health and Social Care (DHSC)
Denham, 7 March 2025 – ITK Engineering, a global technology firm and subsidiary of Robert Bosch, is expanding into the UK MedTech sector. With 30 years of expertise in software and systems engineering, the EN ISO 13485-certified company will support medical innovators in one of the world’s most dynamic healthcare
Basel, 12 March 2025 – Roche has entered into an exclusive collaboration and licensing agreement with Zealand Pharma (a Danish biotechnology research company) to co-develop and co-commercialise Zealand Pharma’s amylin analog, petrelintide. The partnership covers both standalone use and a fixed-dose combination with Roche’s lead incretin asset, CT-388. Under
The intricate relationship between the gut and brain has become a focal point of scientific inquiry, revealing profound implications for mental health. As research advances, the field of psychobiotics—probiotics with potential mental health benefits—is gaining traction, offering new therapeutic possibilities. In a recent interview, Sarunas (George) Baciliunas, Co-Founder